iVaccine-Deep: Prediction of COVID-19 mRNA vaccine degradation using deep learning

Deep learning modeling of RNA ac4C deposition reveals the importance of plant alternative splicing

The N4-acetylcytidine (ac4C) modification has recently been characterized as a noncanonical RNA marker in plants. While the precise installation of ac4C sites in individual plant transcripts continues to present challenges, the biological roles of ac4C in specific plant species are gradually being deciphered. Herein, we utilized a deep learning technique called iac4C (intelligent ac4C) to predict ac4C sites in mRNA. ac4C deposition was effectively forecasted by the iac4C model (AUROC = 0.948), revealing a reliable distribution pattern primarily situated in the transcribing area as opposed to regions that are not translated. The iac4C deep learning approach using a combination of BiGRU and self-attention mechanisms both validates previous studies showing a positive correlation between ac4C and RNA splicing in plant species and reveals new examples of other splicing events associated with ac4C. Our advanced deep learning algorithm for analyzing ac4C enables swift identification of important biological phenomena that would otherwise be challenging to uncover through traditional experimental approaches. These findings provide insight into the essential regulatory function of site-specific ac4C deposition in alternative splicing processes. The source code and datasets for iac4C are available at https://github.com/xlwei507/iac4C .

Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity

Gene therapy is on its way to revolutionize the treatment of both inherited and acquired diseases, by transferring nucleic acids to correct a disease-causing gene in the target cells of patients. In the fight against infectious diseases, mRNA-based therapeutics have proven to be a viable strategy in the recent Covid-19 pandemic. Although a growing number of gene therapies have been approved, the success rate is limited when compared to the large number of preclinical and clinical trials that have been/are being performed. In this review, we highlight some of the hurdles which gene therapies encounter after administration into the human body, with a focus on nucleic acid degradation by nucleases that are extremely abundant in mammalian organs, biological fluids as well as in subcellular compartments. We overview the available strategies to reduce the biodegradation of gene therapeutics after administration, including chemical modifications of the nucleic acids, encapsulation into vectors and co-administration with nuclease inhibitors and discuss which strategies are applied for clinically approved nucleic acid therapeutics. In the final part, we discuss the currently available methods and techniques to qualify and quantify the integrity of nucleic acids, with their own strengths and limitations.

Data-Driven Analytics Leveraging Artificial Intelligence in the Era of COVID-19: An Insightful Review of Recent Developments

This paper presents the role of artificial intelligence (AI) and other latest technologies that were employed to fight the recent pandemic (i.e., novel coronavirus disease-2019 (COVID-19)). These technologies assisted the early detection/diagnosis, trends analysis, intervention planning, healthcare burden forecasting, comorbidity analysis, and mitigation and control, to name a few. The key-enablers of these technologies was data that was obtained from heterogeneous sources (i.e., social networks (SN), internet of (medical) things (IoT/IoMT), cellular networks, transport usage, epidemiological investigations, and other digital/sensing platforms). To this end, we provide an insightful overview of the role of data-driven analytics leveraging AI in the era of COVID-19. Specifically, we discuss major services that AI can provide in the context of COVID-19 pandemic based on six grounds, (i) AI role in seven different epidemic containment strategies (a.k.a non-pharmaceutical interventions (NPIs)), (ii) AI role in data life cycle phases employed to control pandemic via digital solutions, (iii) AI role in performing analytics on heterogeneous types of data stemming from the COVID-19 pandemic, (iv) AI role in the healthcare sector in the context of COVID-19 pandemic, (v) general-purpose applications of AI in COVID-19 era, and (vi) AI role in drug design and repurposing (e.g., iteratively aligning protein spikes and applying three/four-fold symmetry to yield a low-resolution candidate template) against COVID-19. Further, we discuss the challenges involved in applying AI to the available data and privacy issues that can arise from personal data transitioning into cyberspace. We also provide a concise overview of other latest technologies that were increasingly applied to limit the spread of the ongoing pandemic. Finally, we discuss the avenues of future research in the respective area. This insightful review aims to highlight existing AI-based technological developments and future research dynamics in this area.